Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Sichuan Huiyu Pharmaceutical Co., Ltd clinical trials
The registry lists 16 studies whose lead sponsor is Sichuan Huiyu Pharmaceutical Co., Ltd. 10 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the Sichuan Huiyu Pharmaceutical Co., Ltd studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sichuan Huiyu Pharmaceutical Co., Ltd.
- Sichuan Huiyu Pharmaceutical Co., Ltd16 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 16 of 16.
- A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver GenesRecruitingNCT06712680Phase 1/2
- Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid TumorsRecruitingNCT06639256Phase 1/2
- Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast CancerRecruitingNCT06765590Not applicable
- Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting ConditionsRecruitingNCT07606105Phase 1
- A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting ConditionsRecruitingNCT07790562Phase 1
- Phase 1/2 Clinical Study of HY07121 for Injection (Subcutaneous) in Patients With Advanced Solid TumorsNot yet recruitingNCT07789327Phase 1/2
- A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat AccumulationRecruitingNCT06756490Phase 1
- A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid TumorsRecruitingNCT07069062Phase 1/2
- Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS MutationRecruitingNCT06243354Phase 1/2
- A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid TumorsRecruitingNCT07083323Phase 1/2
- Human Bioequivalence Study of Liposomal Amphotericin B for InjectionCompletedNCT06983665Not applicable
- Human Bioequivalence Study of Amphotericin B Liposome for InjectionCompletedNCT06977490Not applicable
- Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese ParticipantsCompletedNCT06895993Phase 1
- Bioequivalence Study of Iron Sucrose Injection in Healthy ParticipantsCompletedNCT06674486Phase 1
- Bioequivalence Study of Iron Sucrose Injection in Healthy SubjectsCompletedNCT06622148Phase 1
- Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency AnaemiaCompletedNCT06080555Phase 1